⌘ Services
mob-logo
Contact Quote Order Login / Register
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Custom Citrullinated Peptide Synthesis

Site-specific incorporation of L-citrulline for post-translational modification research, epitope mapping, proteomics, antibody studies, and assay development.

Request a Quote Speak with a Scientist
Overview Benefits Options Applications Workflow Related Services Quality FAQ Contact
Scientific Overview

Citrullinated Peptides

Precise, site-specific incorporation for mechanistic, immunological, and analytical research

Citrullination, also known as deimination, is a post-translational modification in which peptidyl-arginine is converted to peptidyl-citrulline by peptidylarginine deiminase (PAD) enzymes. This reaction replaces the positively charged guanidinium group with a neutral ureido group, producing a characteristic +0.9840 Da mass shift.

Although chemically subtle, citrullination can alter electrostatic interactions, protein conformation, proteolytic susceptibility, chromatographic behavior, and molecular recognition. Site-defined synthetic peptides provide reliable tools for studying PAD substrate specificity, autoimmune epitopes, biomarker candidates, and structure–function relationships.

Bio-Synthesis incorporates protected Fmoc-L-citrulline directly during solid-phase peptide synthesis (SPPS), enabling precise site-specific installation without enzymatic conversion. Citrullinated peptides can also be combined with stable isotopes, affinity tags, fluorophores, and additional PTMs for advanced research applications.

Site-Specific Precision Install citrulline at defined sequence positions.
Excellent Fidelity Direct SPPS incorporation supports reproducible sequence control.
PTM Compatibility Combine with labels, isotopes, linkers, and other modifications.
Research Confidence Create matched standards and defined experimental controls.
Research Advantages

Benefits of Citrullinated Peptide Modification

Synthetic citrullinated peptides provide defined, reproducible materials for comparing modified and unmodified sequences across mechanistic, immunological, and analytical studies.

01 Defined PTM

Precise PTM Modeling

Reproduce selected citrullination sites with defined sequence context, avoiding the variability of partial enzymatic conversion.

02 Charge Effect

Controlled Charge Comparison

Evaluate how conversion of positively charged arginine to neutral citrulline influences binding, recognition, and conformation.

03 Matched Controls

Reproducible Modified Standards

Create matched arginine and citrulline peptide sets with consistent composition for comparative assays and analytical workflows.

04 Flexible Design

Compatibility with Complex Designs

Combine citrullination with stable isotopes, affinity tags, fluorophores, selected PTMs, or structural modifications.

Citrullinated Peptide Design Options

Projects can be configured around modification count, peptide architecture, labeling, analytical use, and downstream assay requirements.

01

Single-Site Citrullination

One arginine position is replaced with citrulline for focused structure–function or epitope studies.

02

Multiple Citrullination Sites

Two or more defined citrulline residues can be incorporated to reproduce complex modification patterns.

03

Matched Peptide Sets

Arginine-containing and citrullinated analogs can be produced as paired controls for comparative assays.

04

Multi-Modified Peptides

Citrullination can be combined with selected PTMs, labels, or conjugation handles after compatibility review.

05

Stable-Isotope Standards

Heavy amino acids can be introduced for targeted LC-MS and quantitative proteomic applications.

06

Long & Difficult Sequences

Sequence-dependent optimization is available for hydrophobic, aggregation-prone, or highly modified peptides.

Compatible Peptide Modifications

Citrullination may be combined with other modifications when the complete sequence, protecting-group strategy, purification plan, and final application are considered together.

PTM

Biological & Analytical Modifications

Options used to model PTM combinations, support detection, or create quantitative reference materials.

Phosphorylation
Acetylation
Methylation
Glycosylation
Stable Isotopes
Biotinylation
Fluorescent Dyes
DESIGN

Structural & Functional Modifications

Options used to control spacing, conformation, immobilization, or downstream conjugation.

PEG Spacers
Cyclization
Stapling
Azide Handles
Alkyne Handles
Maleimide Chemistry
Other Reactive Handles

Compatibility review: not every modification combination is equally practical. Final feasibility depends on sequence, modification position, protecting-group strategy, purification behavior, and the intended assay.

Research Use

Typical Research Applications

Citrullinated peptides serve as defined research tools, reference materials, substrates, antigens, and assay components. Because these are applications rather than sequential steps, the content is presented as a compact research-use matrix without workflow numbering.

PTM

PTM & Structure–Function Research

Evaluate how arginine-to-citrulline conversion changes charge, conformation, molecular recognition, and peptide behavior.

MAP

Epitope Mapping

Compare matched modified and unmodified sequences to identify citrullination-dependent antibody or immune recognition.

ACPA

Autoimmune Research

Prepare defined citrullinated antigens for anti-citrullinated protein antibody (ACPA), rheumatoid arthritis, and related immunological research.

PAD

PAD Enzyme Studies

Use controlled peptide substrates and reference products for enzyme specificity, kinetics, and inhibitor evaluation.

MS

Proteomics & LC-MS

Support method development, site confirmation, chromatographic comparison, and quantitative mass-spectrometry workflows.

ASSAY

Assay Development

Generate peptide reagents for ELISA, antibody characterization, biomarker research, and diagnostic-development studies.

Design Considerations

Successful projects balance biological relevance with synthesis, purification, solubility, and analytical requirements.

Sequence & Modification Planning

  • Select literature-supported or experimentally identified citrullination sites.
  • Consider matched arginine and citrulline peptide controls.
  • Assess whether single-site or multi-site modification best represents the intended model.
  • Review the compatibility of additional PTMs, labels, or structural modifications.

Purification & Analysis

  • Account for sequence-dependent solubility and RP-HPLC retention changes.
  • Select purity according to screening, immunological, or quantitative use.
  • Use LC-MS or high-resolution MS to support identity confirmation.
  • Apply additional analytical testing when required by the application.

Integrated Manufacturing Workflow

From sequence consultation and citrullination strategy through custom synthesis, purification, analytical characterization, and final product release.

PHASE 1

Design & Planning

01

Sequence Review

Assess peptide length, composition, arginine positions, solubility risk, and intended application.

02

Citrullination Strategy

Define single- or multi-site incorporation, matched controls, purity, scale, and compatible labels.

PHASE 2

Custom Synthesis

03

SPPS with L-Citrulline

Incorporate protected L-citrulline directly at selected positions using a sequence-specific synthesis plan.

04

Modification Integration

Add compatible PTMs, isotope labels, biotin, fluorophores, spacers, or reactive handles when required.

PHASE 3

Purification & Release

05

Preparative Purification

Apply a sequence-appropriate HPLC method and optimize fraction selection for the requested purity.

06

Analytical QC & Release

Confirm identity and purity by LC-MS and analytical HPLC with project-specific documentation.

Frequently Asked Questions

Practical guidance for planning custom citrullinated peptide projects.

FAQ

What is a citrullinated peptide?
A citrullinated peptide contains one or more site-defined citrulline residues corresponding to arginine-to-citrulline deimination in a native or designed sequence.
How are citrullinated peptides synthesized?
Protected L-citrulline building blocks are incorporated directly during solid-phase peptide synthesis, giving precise control over residue position.
Can multiple citrulline residues be incorporated?
Yes. Single-site and multi-site citrullinated peptides are supported after sequence, scale, and purification review.
Can citrullination be combined with other peptide modifications?
Yes. Citrulline can be combined with many PTMs, labels, stable isotopes, structural modifications, and reactive handles when the complete chemistry is compatible.
Are citrullinated peptides suitable for LC-MS studies?
Yes. Synthetic citrullinated peptides are frequently used for method development, site confirmation, retention studies, and quantitative workflows.
What purity should I request?
The appropriate purity depends on the application. Screening may tolerate lower purity, while immunological, analytical, and quantitative studies usually benefit from higher-purity material.
Can citrullinated peptides be labeled with biotin or fluorescent dyes?
Yes. Biotin, fluorescent dyes, PEG spacers, stable isotopes, and selected reactive handles can be incorporated following sequence and compatibility review.
Can Bio-Synthesis help optimize the design?
Yes. Scientific review can address site selection, sequence length, matched controls, solubility, purity, labeling, and analytical characterization.
More FAQ'sAll FAQ's
Scientific Consultation & Quote

Need Help Designing a Citrullinated Peptide?

Share your peptide sequence, desired citrullination sites, matched-control requirements, intended application, scale, purity, and any additional labels or modifications. Our peptide scientists can evaluate synthetic feasibility, solubility risk, modification compatibility, purification strategy, and analytical requirements before manufacturing begins.
Request a Quote Consult a Peptide Scientist

Need help before quoting?

Email: info@biosyn.com
Phone: 800-227-0627 (US/CAN)
Phone: +001-972-420-8505 (INT)

What to Send

  • Peptide sequence and citrullination position(s)
  • Native or arginine-containing control sequence
  • Research objective and downstream assay
  • Additional PTMs, labels, linkers, or isotope residues
  • Required quantity, purity, and formulation
  • Preferred analytical or release documentation
  • Relevant structure or literature reference

What We Review

Our scientists review sequence complexity, citrulline placement, aggregation and solubility risk, orthogonal chemistry, coexisting modifications, purification resolution, scale, and project-specific analytical QC. When a requested route is impractical, we explain the limitation and propose a scientifically sound alternative.

Quality Systems & Manufacturing Support

Integrated Support from Research Scale to Manufacturing

Each citrullinated peptide project moves through a defined sequence of scientific review, controlled synthesis, purification and analytical confirmation, and final release. The level of documentation and testing is aligned with peptide complexity, intended use, scale, and project-specific requirements.

01

Scientific & Sequence Review

Feasibility is assessed before manufacturing begins so citrulline placement, peptide behavior, and downstream requirements are incorporated into the project plan.

  • Sequence and modification-site review
  • Matched-control planning
  • Solubility and aggregation risk assessment
02

Controlled Peptide Manufacturing

Protected Fmoc-L-citrulline is incorporated through a documented SPPS route with controls selected for sequence length and modification complexity.

  • Defined synthesis and coupling strategy
  • Site-specific citrulline incorporation
  • Compatibility with additional modifications
03

Purification & Analytical Confirmation

Purification and analytical methods are selected together to resolve the target peptide and confirm identity after synthesis and cleavage.

  • Preparative HPLC purification
  • Analytical HPLC purity assessment
  • Mass spectrometric identity confirmation
04

Release, Documentation & Scale-Up

Final release testing, formulation, and documentation are matched to the research program, with pathways available for repeat production and larger scales.

  • Project-specific release documentation
  • Optional advanced characterization
  • Research-to-pilot scale support
Quality Frameworks Supporting Manufacturing

Bio-Synthesis operates within established quality and environmental management frameworks that support documented peptide manufacturing, analytical review, traceability, and continuous process improvement.

ISO 9001:2015 ISO 13485:2016 GLP Support ISO 14001
Project-Specific Testing

Optional testing may include amino acid analysis, peptide content, solubility evaluation, counterion analysis, or other characterization selected for the intended application.

Scientific Background & Recommended Reading

Recommended Reading

Selected peer-reviewed literature supporting protein arginine deimination, PAD biology, citrullinated epitopes, and analytical characterization of citrullinated peptides.

  1. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn GJM. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays. 2003;25:1106–1118.
  2. György B, Tóth E, Tarcsa E, Falus A, Buzás EI. Citrullination: a post-translational modification in health and disease. International Journal of Biochemistry & Cell Biology. 2006;38:1662–1677.
  3. Wang S, Wang Y. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochimica et Biophysica Acta. 2013;1829:1126–1135.
  4. Clancy KW, Weerapana E, Thompson PR. Detection and identification of protein citrullination in complex biological systems. Current Opinion in Chemical Biology. 2016;30:1–6.
  5. Tilvawala R, Thompson PR. Peptidyl arginine deiminases: detection and functional analysis of protein citrullination. Current Opinion in Structural Biology. 2019;59:205–215.

Scientific note: Synthetic citrullinated peptides provide precise control over sequence, modification position, and matched controls. Experimental behavior can still depend on peptide length, neighboring residues, charge distribution, solubility, and assay format, so design should be evaluated in the context of the intended study.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.

Greetings, Researchers,

Please be advised that any information, guidelines, write-ups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the design of products intended for their experiments before submitting
their designs to Biosynthesis for production feasibility review.
Thank you for your understanding.

Quick Links